Efficacy and safety of CT-P59 plus standard of care: a phase 2/3 randomized, double-blind, placebo-controlled trial in outpatients with mild-to-moderate SARS-CoV-2 infection
- DOI
- 10.21203/rs.3.rs-296518/v1
- Published
- 2021-03-15
- Container
- Not recorded
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21203/rs.3.rs-296518/v1,
title = {Efficacy and safety of CT-P59 plus standard of care: a phase 2/3 randomized, double-blind, placebo-controlled trial in outpatients with mild-to-moderate SARS-CoV-2 infection},
author = {Joong Sik Eom and Michael Ison and Anca Streinu-Cercel and Oana Săndulescu and Liliana-Lucia Preotescu and Yeon-Sook Kim and Jin Yong Kim and Shin Hyea Cheon and Young Rock Jang and Sang Joon Lee and Sung Hyun Kim and Ilsung Chang and Jee Hye Suh and Seul Gi Lee and Mi Rim Kim and Da Rae Chung and Han Na Kim and Adrian Streinu-Cercel},
year = {2021},
doi = {10.21203/rs.3.rs-296518/v1},
url = {https://doi.org/10.21203/rs.3.rs-296518/v1}
}RIS
TY - JOUR TI - Efficacy and safety of CT-P59 plus standard of care: a phase 2/3 randomized, double-blind, placebo-controlled trial in outpatients with mild-to-moderate SARS-CoV-2 infection AU - Joong Sik Eom AU - Michael Ison AU - Anca Streinu-Cercel AU - Oana Săndulescu AU - Liliana-Lucia Preotescu AU - Yeon-Sook Kim AU - Jin Yong Kim AU - Shin Hyea Cheon AU - Young Rock Jang AU - Sang Joon Lee AU - Sung Hyun Kim AU - Ilsung Chang AU - Jee Hye Suh AU - Seul Gi Lee AU - Mi Rim Kim AU - Da Rae Chung AU - Han Na Kim AU - Adrian Streinu-Cercel PY - 2021 DO - 10.21203/rs.3.rs-296518/v1 UR - https://doi.org/10.21203/rs.3.rs-296518/v1 ER -
APA
Eom, J. S., Ison, M., Streinu-Cercel, A., Săndulescu, O., Preotescu, L., Kim, Y., Kim, J. Y., Cheon, S. H., Jang, Y. R., Lee, S. J., Kim, S. H., Chang, I., Suh, J. H., Lee, S. G., Kim, M. R., Chung, D. R., Kim, H. N., & Streinu-Cercel, A. (2021). Efficacy and safety of CT-P59 plus standard of care: a phase 2/3 randomized, double-blind, placebo-controlled trial in outpatients with mild-to-moderate SARS-CoV-2 infection. https://doi.org/10.21203/rs.3.rs-296518/v1
Source records
- crossref · retrieved 2026-09-27T03:47:35.072Z